Last reviewed · How we verify
NCT05872646
The Effect of Cognitive Functions on Upper Extremity Functionality in Parkinson's Patients
NA trial testing clinical assessment in Parkinson in 104 participants. Completed in 10 March 2023.
10 March 2023
Quick facts
| Lead sponsor | Pamukkale University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 104 |
| Start date | 8 February 2018 |
| Primary completion | 10 March 2023 |
| Estimated completion | 10 March 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- clinical assessment — full drug profile →
Conditions studied
- Parkinson — all drugs for Parkinson →
- Cognitive Impairment — all drugs for Cognitive Impairment →
- Upper Extremity Problem — all drugs for Upper Extremity Problem →
- Functional Disturbance — all drugs for Functional Disturbance →
Sponsor
Pamukkale University
Who can join
Adults 30 to 80, any sex, with Parkinson or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parkinson's Disease (PD), first described by James Parkinson in 1817, is a progressive movement disorder that develops mainly as a result of the destruction of nigrostriatal dopaminergic neurons. The aim of our study is to determine the effect of cognitive functions on upper extremity functionality in individuals with Parkinson's Disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05872646
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of clinical assessment
Trials testing the same drug.
- NCT07469566 — Characterization of the Natural History of Microduplication Syndrome 7q11.23 · NA · not yet recruiting
- NCT07208370 — Outcomes of Gillian Barrie Syn · NA · not yet recruiting
- NCT06826287 — 7T Anatomo-functional Characterization of Structures in the Action Observation Network · recruiting
- NCT07294105 — Relationship Between Periodontal Disease and Postmenopausal Osteoporosis · completed
- NCT05290649 — Respiratory Functions and Muscle Strength, Trunk Control, Functional Capacity and Independence in Hemiplegic Patients · completed
Other recruiting trials for Parkinson
Currently open trials in the same condition.
- NCT07402928 — Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's · recruiting
- NCT07148700 — Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functi · recruiting
- NCT05931692 — Virtual Reality and Fear of Falling in Parkinson's Disease · recruiting
- NCT05286736 — Neuroplasticity in Parkinson's Disease · recruiting
- NCT03672266 — Studies of Brain and Body Interaction · recruiting
Other Pamukkale University trials
Trials by the same sponsor.
- NCT06667856 — Foot Core Exercise Training With Telerehabilitation · NA · suspended
- NCT07532499 — EMG-Triggered Electrical Stimulation After Median/Ulnar Nerve Repairs · NA · not yet recruiting
- NCT07473232 — Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoart · NA · not yet recruiting
- NCT07520084 — Predictors of Climate Change Health Literacy in Older Individuals · recruiting
- NCT07388316 — Functional Improvement and Fine Dexterity in Thumb Tendon Injuries · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05872646 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pamukkale University
- Last refreshed: 24 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05872646.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing